GE Capital, which once generated nearly half of its parent company’s profits, has been affecting General Electric’s (GE) stock price since 2008.
At first glance, one might wonder about the sudden rise in General Electric’s (GE) Industrial plus Verticals debt-to-equity in the last two quarters.
In April 2015, General Electric’s (GE) chair and CEO Jeffrey Immelt announced plans to downsize the company’s financial services (XLF) business.
GE Capital is the financial services unit of the American conglomerate General Electric (GE). It contributed ~9% to GE’s total consolidated revenue in 2015.
Following the 2008 financial crisis, General Electric’s (GE) financial services business had substantial exposure to wholesale funding and underwriting.
This is not the first time Marvell’s management has been questioned. In 2008, it was found guilty of backdating stock options to reward its executives.
The BOE (Bank of England) released the Financial Stability Report on July 5, 2016. It warned multiple times about the repercussions of a Brexit.
A Canadian high court canceled approval for Enbridge’s (ENB) Northern Gateway Project on June 30, 2016. The Northern Gateway Project consists of a 1,177-km pipeline from Alberta across northern British Columbia to the Kitimat port.
In 2015, Qualcomm earned 53% of revenue from China and ~90% of operating income from licensing. But many Chinese handset makers underreported their sales.
Qualcomm claims to have signed new deals with over 100 Chinese handset makers, including the top five vendors.
The CHMP withdrew Mylan’s (MYL) Alendronic Acid, Insmed’s Arikayce, Sun Pharmaceuticals’ Docetaxel Sun, and BioMarin’s (BMRN) Kyndrisa in its June meeting.
The European Medicines Agency’s CHMP (Committee for Medicinal Products for Human Use) recommended the suspension of Alkem’s Riluzole Alkem on June 24, 2016.
The European Medicines Agency’s CHMP gave a negative recommendation to Novartis’s Arzerra for use as a maintenance treatment for CLL on June 23, 2016.
The European Medicines Agency’s CHMP gave positive recommendations to seven medicines for the extension of therapeutic indications in its June meeting.
The European Medicines Agency’s CHMP gave positive recommendations to six new medicines in its June 23, 2016, meeting.
The European Medicines Agency’s CHMP (Committee for Medicinal Products for Human Use) prepares opinions on the quality, safety, and efficacy of medicines.
Currently, there aren’t controls for crossing borders between European Union member states. This could change after Brexit. It would add to travel costs.
Brexit will likely add to airlines’ costs. Naturally, airlines with the highest exposure to the United Kingdom’s markets stand to lose the most.
After Brexit, the pound fell to a 30-year low on June 24, 2016. Traveling to the United Kingdom just got a lot cheaper for US travelers.
Although the entire market was down, the travel industry, specifically airlines, faced most of the impact. American Airlines was the biggest loser—it fell by ~11%.